# A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

> **NCT01444430** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12460 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Symbicort pMDI
- **DRUG:** budesonide pMDI

## Key facts

- **NCT ID:** NCT01444430
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 12460 (ACTUAL)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444430, "A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01444430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*